Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TAK1 regulates skeletal muscle mass and mitochondrial function
Sajedah M. Hindi, Shuichi Sato, Guangyan Xiong, Kyle R. Bohnert, Andrew A. Gibb, Yann S. Gallot, Joseph D. McMillan, Bradford G. Hill, Shizuka Uchida, Ashok Kumar
Sajedah M. Hindi, Shuichi Sato, Guangyan Xiong, Kyle R. Bohnert, Andrew A. Gibb, Yann S. Gallot, Joseph D. McMillan, Bradford G. Hill, Shizuka Uchida, Ashok Kumar
View: Text | PDF
Research Article Metabolism Muscle biology

TAK1 regulates skeletal muscle mass and mitochondrial function

  • Text
  • PDF
Abstract

Skeletal muscle mass is regulated by a complex array of signaling pathways. TGF-β–activated kinase 1 (TAK1) is an important signaling protein, which regulates context-dependent activation of multiple intracellular pathways. However, the role of TAK1 in the regulation of skeletal muscle mass remains unknown. Here, we report that inducible inactivation of TAK1 causes severe muscle wasting, leading to kyphosis, in both young and adult mice.. Inactivation of TAK1 inhibits protein synthesis and induces proteolysis, potentially through upregulating the activity of the ubiquitin-proteasome system and autophagy. Phosphorylation and enzymatic activity of AMPK are increased, whereas levels of phosphorylated mTOR and p38 MAPK are diminished upon inducible inactivation of TAK1 in skeletal muscle. In addition, targeted inactivation of TAK1 leads to the accumulation of dysfunctional mitochondria and oxidative stress in skeletal muscle of adult mice. Inhibition of TAK1 does not attenuate denervation-induced muscle wasting in adult mice. Finally, TAK1 activity is highly upregulated during overload-induced skeletal muscle growth, and inactivation of TAK1 prevents myofiber hypertrophy in response to functional overload. Overall, our study demonstrates that TAK1 is a key regulator of skeletal muscle mass and oxidative metabolism.

Authors

Sajedah M. Hindi, Shuichi Sato, Guangyan Xiong, Kyle R. Bohnert, Andrew A. Gibb, Yann S. Gallot, Joseph D. McMillan, Bradford G. Hill, Shizuka Uchida, Ashok Kumar

×

Figure 8

Role of TAK1 in overload-induced myofiber hypertrophy in adult mice.

Options: View larger image (or click on image) Download as PowerPoint
Role of TAK1 in overload-induced myofiber hypertrophy in adult mice.
(A)...
(A) Four-month-old WT mice were subjected to bilateral synergistic ablation (SA) by surgical removal of GA and soleus muscles to induce overload hypertrophy in plantaris muscles. After 7 days, plantaris muscle was isolated and processed for biochemical analysis. Representative gel showing phosphorylated MKK6 protein in in vitro kinase assay (KA) in plantaris muscle. Immunoblots showing levels of phosphorylated and total TAK1 and mTOR protein. (B) Densitometry quantification of TAK1 enzymatic activity and phosphorylated vs. total levels of TAK1 and mTOR in plantaris muscle of Tak1fl/fl and Tak1mKO mice. n = 4 in each group. Error bars represent ± SEM. *P < 0.05, values significantly different from sham-operated muscle by unpaired t test. In another experiment, 14-week-old Tak1fl/fl and Tak1mKO mice were given i.p. injections of tamoxifen, and immediately thereafter, the mice were subjected to SA surgery. After 14 days, the mice were euthanized. One side plantaris muscle was collected and processed for biochemical examination, while the other side was processed for histological analysis. (C) Average wet weight of plantaris muscle of sham and SA-14 Tak1fl/fl and Tak1mKO mice. Representative photomicrographs of plantaris muscle sections of Tak1fl/fl and Tak1mKO mice after (D) anti-dystrophin staining and (E) H&E staining. Scale bars: 20 μm. (F) Quantification of average fiber CSA in dystrophin-stained plantaris muscle sections of Tak1fl/fl and Tak1mKO mice. n = 5–7 in each group. Error bars represent ± SEM. *P < 0.05 values significantly different from sham-operated muscle of Tak1fl/fl mice by 1-way ANOVA with post hoc Bonferroni’s multiple comparison test. #P < 0.05, values significantly different from SA-14 Tak1fl/fl mice by 1-way ANOVA with post hoc Bonferroni’s multiple comparison test. (G) Representative immunoblots of phosphorylated and total Akt, mTOR, and 4E-BP1 protein levels and unrelated protein GAPDH in plantaris muscle of Tak1fl/fl and Tak1mKO mice. (H) Densitometry quantification of the ratio of phosphorylated vs. total protein levels of Akt, mTOR, and 4E-BP1 in plantaris muscle of Tak1fl/fl and Tak1mKO mice 14 days after SA surgery. n = 3 in each group. Error bars represent ± SEM. *P < 0.05 values significantly different from Tak1fl/fl mice by unpaired 2-tailed t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts